Article

Familial Cancer

, Volume 9, Issue 2, pp 253-260

Evolving perspectives on genetic discrimination in health insurance among health care providers

  • Carin R. HuizengaAffiliated withDivision of Clinical Cancer Genetics, City of Hope
  • , Katrina LowstuterAffiliated withDivision of Clinical Cancer Genetics, City of Hope
  • , Kimberly C. BanksAffiliated withSt. Joseph Hospital Cancer Genetics Program
  • , Veronica I. LagosAffiliated withDivision of Clinical Cancer Genetics, City of Hope
  • , Virginia O. VandergonAffiliated withCalifornia State University, Northridge
  • , Jeffrey N. WeitzelAffiliated withDivision of Clinical Cancer Genetics, City of Hope Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Previous studies have documented that concerns about genetic discrimination (GD) may influence access to and participation in medically necessary care. We sought to characterize how GD issues influence current cancer genetics professional (CGP) practice, determine if their attitudes regarding GD have changed over time, and compare their knowledge and attitudes regarding laws prohibiting GD to a contemporary cohort of non-genetics clinicians. Members of the National Society of Genetic Counselors Familial Cancer Special Interest Group were invited to complete a 39 item online survey, adapted from previously published instruments. The resulting data were compared to a survey of CGPs published in 2000 and to a contemporary cohort of non-genetics clinicians (n = 1,181). There were 153 qualified respondents. Compared to the historical CGP cohort (n = 163), a significantly greater proportion said they would bill insurance for the cost of genetic testing for themselves (P < 0.0001). Most CGPs (94%) considered the risk of GD to be low to theoretical, concordant with 64% who expressed confidence in existing federal laws prohibiting GD. The mean knowledge score of CGPs regarding GD protective laws was significantly greater than that of non-genetics clinicians (P < 0.001). As barometers of change, CGPs show a migration in opinion over the past 8 years, with decreased fear of GD and greater knowledge of laws prohibiting GD compared to non-genetics clinicians. Better knowledge of GD and protective legislation, may facilitate non-genetics clinician utilization of genetics and personalized medicine.

Keywords

Genetic discrimination Cancer genetics Genetic testing Health insurance Cancer genetics professional